Építés alatt – nem éles oldal
Belépés
LeállítvaNo phase

Connect® Myeloid Disease Registry

Megadott ok: Business objectives have changed

Key facts

Where
Abilene, Akron, Amarillo, Ames, Anderson, Ann Arbor, Augusta, Bakersfield, Bellingham, Berkeley, Bethesda, Billings, Bloomington, Boise, Bolivar, Boynton Beach, Brunswick, Cape Girardeau, Chicago, Christiana, Cleveland, Columbia, Columbus, Concord, Cooperstown, Covington, Cumberland, Dallas, Daytona Beach, Denver, Detroit, Duluth, Dunmore, East Syracuse, Edina, Evanston, Everett, Fayetteville, Flint, Fort Lauderdale, Fresno, Gainesville, Garden City, Grand Rapids, Green Bay, Greenville, Grosse Pointe Woods, Hackensack, Harvey, Huntington Station, Hyannis, Jacksonville, Johnson City, Joliet, Jonesboro, Joplin, Kansas City, Kennewick, Kinston, Knoxville, La Crosse, La Jolla, Lafayette, Lakeland, Lancaster, Lansing, Laredo, Lincoln, Lubbock, Lynchburg, Manchester, Marietta, McAllen, Memphis, Milwaukee, Monterey, Morgantown, Nashville, New Brunswick, New York, Newport News, Ocala, Ogden, Oklahoma City, Olympia, Orlando, Paterson, Pembroke Pines, Pensacola, Peoria, Phoenix, Portland, Providence, Quincy, Racine, Rochester, Roslyn, Round Rock, Saint Joseph, Saint Louis Park, Salem, San Diego, Santa Rosa, Seattle, Sioux City, Skokie, Somerville, Sparta, Spartanburg, Springfield, St Louis, Stamford, Stockton, Temple, The Bronx, Toledo, Topeka, Tucson, Tulsa, Tuscaloosa, Valhalla, Walla Walla, Watertown, Waukesha, West Reading, Westminster, White River Junction, Wichita és York, Egyesült ÁllamokSee the 154 sites

Where in Egyesült Államok

  • Hendrick Cancer CenterAbilene, Egyesült ÁllamokNo longer taking part
  • Summa Health SystemAkron, Egyesült ÁllamokNo longer taking part
  • Texas Oncology - Amarillo Cancer CenterAmarillo, Egyesült ÁllamokNo longer taking part
  • McFarland Clinic, P.C.Ames, Egyesült ÁllamokNo longer taking part
  • St. Vincent Anderson Regional Hospital ResearchAnderson, Egyesült ÁllamokNo longer taking part
  • University of Michigan Health System (UMHS) - University Hospital (University of Michigan Medical CeAnn Arbor, Egyesült ÁllamokNo longer taking part
  • Georgia Regents University Cancer CenterAugusta, Egyesült ÁllamokNo longer taking part
  • Comprehensive Blood & Cancer CenterBakersfield, Egyesült ÁllamokNo longer taking part
  • PeaceHealth St Joseph Cancer CenterBellingham, Egyesült ÁllamokNo longer taking part
  • Alta Bates Summit Comprehensive CancerBerkeley, Egyesült ÁllamokNo longer taking part
  • Sutter East Bay Hospitals (dba Jordan Research and Education Institute - REDI)Berkeley, Egyesült ÁllamokNo longer taking part
  • Center for Cancer and Blood DisordersBethesda, Egyesült ÁllamokNo longer taking part
  • St. Vincent Frontier Cancer CenterBillings, Egyesült ÁllamokNo longer taking part
  • IU Health Bloomington HospitalBloomington, Egyesült ÁllamokNo longer taking part
  • Saint Alphonsus Regional Medical CenterBoise, Egyesült ÁllamokNo longer taking part
  • MCDA - Central Care CenterBolivar, Egyesült ÁllamokNo longer taking part
  • University Cancer InstituteBoynton Beach, Egyesült ÁllamokNo longer taking part
  • Southeast Georgia Health SystemBrunswick, Egyesült ÁllamokNo longer taking part
  • Southeast Cancer CenterCape Girardeau, Egyesült ÁllamokNo longer taking part
  • Rush University Cancer CenterChicago, Egyesült ÁllamokNo longer taking part
  • Delaware Clinical and Laboratory PhysiciansChristiana, Egyesült ÁllamokNo longer taking part
  • ClevelandCleveland, Egyesült ÁllamokNo longer taking part
  • Cleveland Clinic FoundationCleveland, Egyesült ÁllamokNo longer taking part
  • University Hospitals Case Medical CenterCleveland, Egyesült ÁllamokNo longer taking part
  • Boone Hospital CenterColumbia, Egyesült ÁllamokNo longer taking part
  • Harry S. Truman Memorial Veterans' HospitalColumbia, Egyesült ÁllamokNo longer taking part
  • Maryland Oncology HematologyColumbia, Egyesült ÁllamokNo longer taking part
  • Columbus Regional Research InstituteColumbus, Egyesült ÁllamokNo longer taking part
  • Mid Ohio Oncology/Hematology Inc., DBA The Mark H. Zangmeister CenterColumbus, Egyesült ÁllamokNo longer taking part
  • John Muir Clinical Research CenterConcord, Egyesült ÁllamokNo longer taking part
  • Bassett Heathcare NetworkCooperstown, Egyesült ÁllamokNo longer taking part
  • Mary Bird Perkins Cancer Center at St. TammanyCovington, Egyesült ÁllamokNo longer taking part
  • QCCA - Pontchartrain Cancer CenterCovington, Egyesült ÁllamokNo longer taking part
  • Western Maryland Health SystemCumberland, Egyesült ÁllamokNo longer taking part
  • Dallas VA Medical CenterDallas, Egyesült ÁllamokNo longer taking part
  • HOLD - Texas Oncology, DallasDallas, Egyesült ÁllamokNo longer taking part
  • Texas Oncology Sammons Cancer CenterDallas, Egyesült ÁllamokNo longer taking part
  • Halifax Health Center for OncologyDaytona Beach, Egyesült ÁllamokNo longer taking part
  • Saint Joseph Hospital - Cancer Centers of ColoradoDenver, Egyesült ÁllamokNo longer taking part
  • Henry Ford Health SystemDetroit, Egyesült ÁllamokNo longer taking part
  • John D. Dingell VA Medical Center /Cynthia MarburyDetroit, Egyesült ÁllamokNo longer taking part
  • Essentia Health Oncology Clinical TrialsDuluth, Egyesült ÁllamokNo longer taking part
  • Hematology and Oncology Assoc of NEPADunmore, Egyesült ÁllamokNo longer taking part
  • Hematology Oncology Associates of Central NYEast Syracuse, Egyesült ÁllamokNo longer taking part
  • Southdale Cancer ClinicEdina, Egyesült ÁllamokNo longer taking part
  • Northshore University Health SystemEvanston, Egyesült ÁllamokNo longer taking part
  • Providence Regional Cancer PartnershipEverett, Egyesült ÁllamokNo longer taking part
  • Highlands Oncology GroupFayetteville, Egyesült ÁllamokNo longer taking part
  • Genesys Hurley Cancer InstituteFlint, Egyesült ÁllamokNo longer taking part
  • Holy Cross HospitalFort Lauderdale, Egyesült ÁllamokNo longer taking part
  • VA Central California Health Care SystemFresno, Egyesült ÁllamokNo longer taking part
  • University of FloridaGainesville, Egyesült ÁllamokNo longer taking part
  • Central Care Cancer CenterGarden City, Egyesült ÁllamokNo longer taking part
  • Cancer and Hematology Centers of Western MichiganGrand Rapids, Egyesült ÁllamokNo longer taking part
  • Bellin Memorial Hospital/ Bellin Cancer TeamGreen Bay, Egyesült ÁllamokNo longer taking part
  • St Vincent HospitalGreen Bay, Egyesült ÁllamokNo longer taking part
  • Leo W Jenkins Cancer CenterGreenville, Egyesült ÁllamokNo longer taking part
  • Prisma Health Cancer Institute - UpstateGreenville, Egyesült ÁllamokNo longer taking part
  • Ascension St. John Hospital_Hematology (was St. Johns Hospital and Hematology-Oncology Associates East PC)Grosse Pointe Woods, Egyesült ÁllamokNo longer taking part
  • John Theurer Cancer Center (Hackensack U Med Center)Hackensack, Egyesült ÁllamokNo longer taking part
  • Ingalls Memorial HospitalHarvey, Egyesült ÁllamokNo longer taking part
  • Huntington Medical GroupHuntington Station, Egyesült ÁllamokNo longer taking part
  • Cape Cod HospitalHyannis, Egyesült ÁllamokNo longer taking part
  • Cancer Specialists of North FloridaJacksonville, Egyesült ÁllamokNo longer taking part
  • Johnson CityJohnson City, Egyesült ÁllamokNo longer taking part
  • JolietJoliet, Egyesült ÁllamokNo longer taking part
  • Joliet Oncology Hematology Associates LtdJoliet, Egyesült ÁllamokNo longer taking part
  • JonesboroJonesboro, Egyesült ÁllamokNo longer taking part
  • Clopton Clinic of Jonesboro, Inc.Jonesboro, Egyesült ÁllamokNo longer taking part
  • NEABC- Fowler Family Center for Cancer CareJonesboro, Egyesült ÁllamokNo longer taking part
  • Mercy Cancer Center - JoplinJoplin, Egyesült ÁllamokNo longer taking part
  • Kansas City Veterans Affairs Medical CenterKansas City, Egyesült ÁllamokNo longer taking part
  • Kadlec Regional Medical Center (KRMC)Kennewick, Egyesült ÁllamokNo longer taking part
  • Kinston Medical SpecialistsKinston, Egyesült ÁllamokNo longer taking part
  • Thompson Cancer Survival CenterKnoxville, Egyesült ÁllamokNo longer taking part
  • University of Tennessee Medical Center Cancer IntituteKnoxville, Egyesült ÁllamokNo longer taking part
  • Gundersen Lutheran IncLa Crosse, Egyesült ÁllamokNo longer taking part
  • UCSD Moores Cancer CenterLa Jolla, Egyesült ÁllamokNo longer taking part
  • Horizon Oncology Research, Inc.Lafayette, Egyesült ÁllamokNo longer taking part
  • Watson Clinic Center for Cancer Care and ResearchLakeland, Egyesült ÁllamokNo longer taking part
  • Lancaster Cancer CenterLancaster, Egyesült ÁllamokNo longer taking part
  • Lancaster General HospitalLancaster, Egyesült ÁllamokNo longer taking part
  • Michigan State University, Breslin Cancer CenterLansing, Egyesült ÁllamokNo longer taking part
  • Oncology and Hematology of South Texas, PALaredo, Egyesült ÁllamokNo longer taking part
  • Southeast Nebraska Cancer CenterLincoln, Egyesült ÁllamokNo longer taking part
  • Southwest Cancer Treatment & Research CenterLubbock, Egyesült ÁllamokNo longer taking part
  • Lynchburg Hematology-Oncology ClinicLynchburg, Egyesült ÁllamokNo longer taking part
  • Regional Cancer Care AssociatesManchester, Egyesült ÁllamokNo longer taking part
  • VA Medical Center ManchesterManchester, Egyesült ÁllamokNo longer taking part
  • Northwest Georgia Oncology Centers, P.C.Marietta, Egyesült ÁllamokNo longer taking part
  • Texas Oncology, McAllen (plus 2 satelite sites)McAllen, Egyesült ÁllamokNo longer taking part
  • Regional One HealthMemphis, Egyesült ÁllamokNo longer taking part
  • Columbia St. Mary'SMilwaukee, Egyesült ÁllamokNo longer taking part
  • Pacific Cancer CareMonterey, Egyesült ÁllamokNo longer taking part
  • West Virginia UniversityMorgantown, Egyesült ÁllamokNo longer taking part
  • Vanderbilt-Ingram Cancer CenterNashville, Egyesült ÁllamokNo longer taking part
  • Saint Peter's University HospitalNew Brunswick, Egyesült ÁllamokNo longer taking part
  • Weill Cornell Medical CollegeNew York, Egyesült ÁllamokNo longer taking part
  • Peninsula Cancer InstituteNewport News, Egyesült ÁllamokNo longer taking part
  • Ocala OncologyOcala, Egyesült ÁllamokNo longer taking part
  • Community Cancer Trials of UtahOgden, Egyesült ÁllamokNo longer taking part
  • INTEGRIS Cancer Institute of Oklahoma Proton CampusOklahoma City, Egyesült ÁllamokNo longer taking part
  • INTEGRIS Cancer Institute Southwest Medical CenterOklahoma City, Egyesült ÁllamokNo longer taking part
  • Vista Oncology Inc PSOlympia, Egyesült ÁllamokNo longer taking part
  • Adventist Health System/Sunbelt, Inc.Orlando, Egyesült ÁllamokNo longer taking part
  • St Joseph Healthcare SystemPaterson, Egyesült ÁllamokNo longer taking part
  • Memorial Healthcare SystemPembroke Pines, Egyesült ÁllamokNo longer taking part
  • Sacred Heart Medical Oncology GroupPensacola, Egyesült ÁllamokNo longer taking part
  • Illinois Cancer CarePeoria, Egyesült ÁllamokNo longer taking part
  • Arizona OncologyPhoenix, Egyesült ÁllamokNo longer taking part
  • PortlandPortland, Egyesült ÁllamokNo longer taking part
  • Providence Cancer CenterPortland, Egyesült ÁllamokNo longer taking part
  • Roger Williams Medical CenterProvidence, Egyesült ÁllamokNo longer taking part
  • Quincy Medical GroupQuincy, Egyesült ÁllamokNo longer taking part
  • Wheaton Franciscan Cancer Care - All SaintsRacine, Egyesült ÁllamokNo longer taking part
  • Rochester General HospitalRochester, Egyesült ÁllamokNo longer taking part
  • St. Francis HospitalRoslyn, Egyesült ÁllamokNo longer taking part
  • Scott & White HealthcareRound Rock, Egyesült ÁllamokNo longer taking part
  • Heartland Regional Medical Center (Heartland Health)Saint Joseph, Egyesült ÁllamokNo longer taking part
  • Metro MN CCOP/Park Nicollet InstituteSaint Louis Park, Egyesült ÁllamokNo longer taking part
  • Salem HealthSalem, Egyesült ÁllamokNo longer taking part
  • San DiegoSan Diego, Egyesült ÁllamokNo longer taking part
  • Santa RosaSanta Rosa, Egyesült ÁllamokNo longer taking part
  • Benaroya Research Institute at Virginia MasonSeattle, Egyesült ÁllamokNo longer taking part
  • Swedish Cancer InstituteSeattle, Egyesült ÁllamokNo longer taking part
  • Siouxland Hematology Oncology AssociatesSioux City, Egyesült ÁllamokNo longer taking part
  • Edward H. Kaplan MD & AssociatesSkokie, Egyesült ÁllamokNo longer taking part
  • Orchard Healthcare Research Inc.Skokie, Egyesült ÁllamokNo longer taking part
  • Somerset Medical Center 110 Rehill AvenueSomerville, Egyesült ÁllamokNo longer taking part
  • Sparta Cancer CenterSparta, Egyesült ÁllamokNo longer taking part
  • Spartanburg Regional Medical CenterSpartanburg, Egyesült ÁllamokNo longer taking part
  • Mercy Research - SpringfieldSpringfield, Egyesült ÁllamokNo longer taking part
  • Simmons Cancer Institute at Southern Illinois UniversitySpringfield, Egyesült ÁllamokNo longer taking part
  • St LouisSt Louis, Egyesült ÁllamokNo longer taking part
  • Missouri Baptist Medical CenterSt Louis, Egyesült ÁllamokNo longer taking part
  • Bennett Cancer Center Stamford HospitalStamford, Egyesült ÁllamokNo longer taking part
  • St. Joseph's Regional Cancer CenterStockton, Egyesült ÁllamokNo longer taking part
  • Baylor Research Institute dba Scott & White Memorial HospitalTemple, Egyesült ÁllamokNo longer taking part
  • New York Cancer and Blood SpecialistsThe Bronx, Egyesült ÁllamokNo longer taking part
  • University of Toledo Medical Center (Utmc)Toledo, Egyesült ÁllamokNo longer taking part
  • Cotton O'Neil Clinical Research/ Stormont Vail HealthTopeka, Egyesült ÁllamokNo longer taking part
  • TucsonTucson, Egyesült ÁllamokNo longer taking part
  • The University of Arizona Cancer CenterTucson, Egyesült ÁllamokNo longer taking part
  • Oklahoma Cancer Specialist and Research InstituteTulsa, Egyesült ÁllamokNo longer taking part
  • DCH Health System (Lewis and Faye Manderson Cancer Center)Tuscaloosa, Egyesült ÁllamokNo longer taking part
  • New York Medical CollegeValhalla, Egyesült ÁllamokNo longer taking part
  • Providence St. Mary Regional Cancer CenterWalla Walla, Egyesült ÁllamokNo longer taking part
  • Prairie Lakes Health Systen, IncWatertown, Egyesült ÁllamokNo longer taking part
  • Waukesha Memorial HospitalWaukesha, Egyesült ÁllamokNo longer taking part
  • Reading Hospital - McGlinn Cancer InstituteWest Reading, Egyesült ÁllamokNo longer taking part
  • Carroll Regional Cancer CenterWestminster, Egyesült ÁllamokNo longer taking part
  • VA Medical Center - White River JunctionWhite River Junction, Egyesült ÁllamokNo longer taking part
  • Cancer Center of KansasWichita, Egyesült ÁllamokNo longer taking part
  • Cancer Care Associates of YorkYork, Egyesült ÁllamokNo longer taking part

Trial details

Who runs it
Celgene
Trial code
NCT01688011
Record updated
2025. július 3.
Original description
The purpose of the Connect® Myeloid disease registry is to provide unique insights into treatment decisions and treatment patterns as they relate to clinical outcomes of patients with myeloid diseases in routine clinical practice. This disease registry will also evaluate molecular and cellular markers that may provide further prognostic classification which may or may not be predictive of therapy and clinical outcomes.Read full original descriptionShow less

Connect® Myeloid: The Myelofibrosis (MF), Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry

The purpose of the Connect® Myeloid disease registry is to provide unique insights into treatment decisions and treatment patterns as they relate to clinical outcomes of patients with myeloid diseases in routine clinical practice. This disease registry will also evaluate molecular and cellular markers that may provide further prognostic classification which may or may not be predictive of therapy and clinical outcomes.

Inclusion: Patients must be able to provide written informed consent form (ICF); Must be willing and able to complete baseline and follow-up HRQoL instruments, for which patients must be proficient in either English or Spanish; AML patients must be at least 55 years of age at the time of informed consent; MF, ICUS, and MDS patients must be at least 18 years of age at the time of informed consent; Newly diagnosed Idiopathic Cytopenias of Undetermined Significance (ICUS), Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML) patients:; Newly diagnosed primary or secondary disease. To be considered "newly diagnosed", a patient's confirmed diagnosis must be made no more than 60 days prior to the date of consent signature. (An additional 5-day window [i.e., up to 65 days prior to the date of ICF signature] may be allowed in special circumstance upon sponsor approval); Cohort assignment confirmed by central eligibility review. Cohort assignment must also be confirmed by the site; Myelofibrosis (MF) patients:; Patients who initiated their first active systemic treatment for MF and/or MF-related cytopenias within 90 days prior to the date of consent signature. This cohort allows the enrollment of subjects with a diagnosis of Myelodysplastic/Myeloproliferative overlap syndromes (MDS/MPN overlap syndrome); Cohort assignment is confirmed by the site. Central eligibility review is not required; Treated Lower-Risk Myelodysplastic Syndromes (LR-MDS) patients:; Patients who have initiated first active treatment regimen containing at least one non-ESA therapy, within 90 days prior to ICF; Cohort assignment is confirmed by site. Central eligibility review is not required; Luspatercept treated patients:; Patient must have been at least 18 years of age at the start of luspatercept; Among LR-MDS patients, patient must have initiated luspatercept on or after September 1, 2023, must be ESA-naïve and luspatercept must be the first active treatment (as monotherapy or part of a treatment regimen) for their disease; Among all other myeloid malignancies, there is no date restriction for initiation of luspatercept .Patient may have received prior treatment for their disease; Patient must have at least 3 months of follow-up from start of luspatercept treatment at the participating site.

Exclusion: Currently enrolled in any interventional clinical trial where the patient is being treated with an investigational product that cannot be identified; Idiopathic Cytopenias of Undetermined Significance (ICUS), Myelodysplastic Syndromes (MDS) patients who received or are receiving active (disease modifying) therapy for the treatment of MDS prior to the date of informed consent; Acute Myeloid Leukemia (AML) patients who initiated active (disease modifying treatment for AML more than 2 weeks prior to the date of consent; Patient must not be currently or previously enrolled in the Connect Myeloid Registry; Patient must not have received luspatercept as part of a clinical trial; Myelofibrosis (MF) and Myelodysplastic/Myeloproliferative (MDS/MPN) overlap syndrome patients with suspected juvenile myelomonocytic leukemia (JMML); Luspatercept treated patients:; Suspected or proven acute promyelocytic leukemia (APL) (FAB M3 or WHO 2008) based on morphology, immunophenotype, molecular assay or karyotype.

ClinicalTrials.gov NCT01688011

Építés alatt, nem éles – Connect® Myeloid Disease Registry (NCT01688011) – Frontlight Research